What You Should Know:
- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new additions to its CT imaging portfolio at the Radiological Society of North America (RSNA) annual meeting (November 28 – December 2, Chicago, USA). The new CT 5100 – Incisive – features CT Smart Workflow [1], a comprehensive suite of artificial intelligence* (AI) enabled capabilities designed to accelerate CT workflows, enhance diagnostic confidence, and maximize equipment
Read More
AI
AI in Healthcare| AI Impact for Researchers, Clinicians| Policy, News, Analysis, Insights - HIT Consultant
Respira Launches AI Wearable for Lung Function for COPD, COVID, Asthma
What You Should Know:
- Today, Respira is introducing its AI wearable technology to monitor for certain very serious lung conditions. According to the Institute for Health Metrics and Evaluation, COPD (Chronic Obstructive Pulmonary Disease) and COVID-19 were the 3rd and 4th global causes of death during the height of the pandemic. Asthma, according to the World Health Organization, is the most common chronic disease among children.
- Chest wearable uses tiny speakers and microphones to
Read More
Rad AI Nabs $25M to Automate Radiology Impressions, Save Time, Reduce Burnout, Improve Patient Care
What You Should Know:
- Rad AI, a Berkely, CA-based radiologist-led AI company, today announced $25M in Series A funding led by ARTIS Ventures with participation by several existing investors, including OCV Partners, Kickstart Fund, and Gradient Ventures (Google's AI-focused fund).
- Rad AI Omni automatically generates a customized impression from the findings and clinical indication dictated by the radiologist, using the most advanced neural networks. It learns each
Read More
Notable Labs Launches by Acquiring Rights to Volasertib – Will Use Data, AI to Fast-Track Cancer Treatment
What You Should Know:
- Coming out of stealth, Notable Labs, a pioneer and developer of predictive precision medicines, is acquiring worldwide development and commercial rights to volasertib, a PLK-1 inhibitor in acute myeloid leukemia (AML) from Oncoheroes.
- Notable will leverage its high-fidelity Predictive Precision Medicines Platform to identify and select volasertib-responsive patients prior to their treatment and fast-track volasertib’s clinical development
Read More
Caption Health, Ultromics Partner for AI-Powered Heart Disease Detection
What You Should Know:
- Caption Health and Oxford University spin-out Ultromics have teamed up to empower a broader set of healthcare providers and put heart disease detection and management tools in more hands. This is a second strategic partnership that Caption Health secured in the last three months to enable earlier disease detection and management with AI-based guidance and diagnostics.
- Together, the companies will offer the Caption AI™ software platform alongside Ultromics’ EchoGo®
Read More
U of Florida to Deploy DreaMed AI Solution for Type 2 Diabetes
What You Should Know:
- DreaMed Diabetes AI, developer of the AI-powered Advisor Pro Clinical Decision Support System and expert-care platform for diabetes, announced today the expansion of its commercial relationship with the Pediatric Endocrinology Clinic at the University of Florida in Gainesville.
- The clinic will begin using the Advisor Pro Decision-Support System for people with Type 2 and Type 1 diabetes, enhancing its offering to healthcare practitioners and patients.
- Advisor
Read More
Personalized Screening is Key to Breast Imaging AI Market Reaching $205M by 2025
As October draws to a close, so does Breast Cancer Awareness Month (BCAM), or National Breast Cancer Awareness Month (NBCAM) as it is known in the US. Breast imaging AI vendors are heavily promoting this initiative to raise awareness of the disease and highlight the importance of women attending breast cancer screening appointments. Breast cancer screening programs are an important public health intervention, and initiatives like the BCAM may prompt eligible women to attend their screening
Read More
Bayer, One Drop Launches AI-Enabled Cardiovascular Disease Prevention Solution
What You Should Know:
- One Drop, an AI powered chronic condition management platform, and pharma giant Bayer - their strategic partner/investor released their co-developed digital, AI-enabled, cardiovascular disease (CVD) prevention module.
- The digital-first approach to CVD prevention provides a holistic set of digital tools and coaching placing One Drop members on a healthier path by personalizing care, gathering data, and
Read More
Arine Raises $11M to Scale AI-Driven Medication Optimization Platform
What You Should Know:
- Arine, a San Francisco-based AI-driven platform that optimizes medication management, reduces costs and improves outcomes for health plans and providers today announced that it closed $11 million in an oversubscribed Series A round co-led by 111° West Capital Partners and Katalyst Ventures, with strategic investments from Magellan Health Inc. and SCAN Group.
- Medication mismanagement unnecessarily costs healthcare $1 in every $6 spent. Arine optimizes
Read More
Navina Raises $15M for AI-Powered Primary Care Platform
What You Should Know:
- Navina, a Tel Aviv-based developer of AI-powered clinical platform for primary care raises $15M in Series A funding led by Vertex Ventures Israel, Schusterman Family Investments (SFI) and existing investor Grove Ventures also joined the round. The latest round brings the company's total funding to date to $22M, raised within 12 months after commercial launch.
- Navina uses medically informed AI to replace disorganized patient data with an intuitive Patient Portrait
Read More
